HomeInsightsStock Comparison

Medicamen Organics Ltd vs Shilpa Medicare Ltd Stock Comparison

Medicamen Organics Ltd vs Shilpa Medicare Ltd Stock Comparison

Last Updated on: Jun 13, 2025

Key Highlights

  • The Latest Trading Price of Medicamen Organics Ltd is ₹ 46.05 as of 13 Jun 15:30.
  • The P/E Ratio of Medicamen Organics Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Shilpa Medicare Ltd changed from 12.8 on March 2020 to 125.7 on March 2024 . This represents a CAGR of 57.92% over 5 years.
  • The Market Cap of Medicamen Organics Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Shilpa Medicare Ltd changed from ₹ 1993 crore on March 2020 to ₹ 4004 crore on March 2024 . This represents a CAGR of 14.97% over 5 years.
  • The revenue of Medicamen Organics Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Shilpa Medicare Ltd for the Mar '25 is ₹ 340.68 crore as compare to the Dec '24 revenue of ₹ 320.79 crore. This represent the growth of 6.2%.
  • The ebitda of Medicamen Organics Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Shilpa Medicare Ltd for the Mar '25 is ₹ 58.56 crore as compare to the Dec '24 ebitda of ₹ 82.17 crore. This represent the decline of -28.73%.
  • The net profit of Medicamen Organics Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Shilpa Medicare Ltd changed from ₹ 1.18 crore to ₹ 14.51 crore over 8 quarters. This represents a CAGR of 250.67% .
  • The Dividend Payout of Medicamen Organics Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Shilpa Medicare Ltd changed from 4.63 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Medicamen Organics Ltd

  • Medicamen Organics Limited was formerly incorporated on March 15, 1995 as Panchdeep Pharmaceuticals Limited', as Public Limited Company dated March 15, 1995 issued by the Registrar of Companies, Delhi and Haryana.
  • Subsequently, the name of Company changed to Medicamen Organics Limited' and a fresh Certificate of Incorporation on November 14, 1995 was issued by the Registrar of Companies, Delhi and Haryana at Delhi. Medicamen Organics are engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry Powders for Government (including both State and Central Governments) and Private Institutions as contract manufacturer / third party manufacturer.
  • The Company market product to private pharma companies in domestic as well as international markets through third party distributors or on loan license basis.

About Shilpa Medicare Ltd

  • Shilpa Medicare Limited (Formerly known as Shilpa Antibiotics Private Limited) was incorporated as a Private Limited Company on November 20, 1987.
  • The Company changed the status to Public Limited and the name of the Company was changed to Shilpa Antibiotics Limited in November, 1993 and later on, was changed to 'Shilpa Medicare Limited' on February 17, 2003. The Company has been promoted by Vishnukant C. Bhutada and his Associates and is engaged in manufacturing of API, Formulation and Development service.
  • The Company started its operations as API manufacturer way back in 1987 at Raichur, Karnataka.
  • It then started commercial production in November, 1989. The Company is one of the leading API and formulations manufacturers with strong capabilities in the therapeutic area of oncology.

Medicamen Organics Ltd News Hub

News

Medicamen Organics to convene board meeting

Medicamen Organics will hold a meeting of the Board of Directors of the Company on 29 May ...

Read more

27 May 2025 11:04

News

Medicamen Organics to hold board meeting

Medicamen Organics will hold a meeting of the Board of Directors of the Company on 8 Janua...

Read more

04 Jan 2025 10:28

News

Medicamen Organics to discuss results

Medicamen Organics will hold a meeting of the Board of Directors of the Company on 14 Nove...

Read more

09 Nov 2024 14:44

News

Medicamen Organics to conduct AGM

Medicamen Organics announced that the 29th Annual General Meeting (AGM) of the company wil...

Read more

27 Aug 2024 16:29

News

NSE SME Medicamen Organics soars on debut

The scrip was listed at Rs 137.85, a premium of 305.44% over the initial public offer (IPO...

Read more

28 Jun 2024 12:45

Shilpa Medicare Ltd News Hub

News

Board of Shilpa Medicare recommends final dividend

Shilpa Medicare announced that the Board of Directors of the Company at its meeting held o...

Read more

27 May 2025 11:37

News

Shilpa Medicare slides after Q4 PAT drop 41% YoY to Rs 15-cr

Profit before exceptional items and tax stood at Rs 43.35 crore in Q4 FY25, up 100.88% fro...

Read more

27 May 2025 16:01

News

Shilpa Medicare Ltd leads gainers in 'A' group

Netweb Technologies India Ltd, Linde India Ltd, Vaibhav Global Ltd and ITD Cementation Ind...

Read more

26 May 2025 12:00

News

Shilpa Medicare zooms as arm partners with Orion Corporation

Under this strategic agreement, Orion Corporation will serve as the exclusive partner for ...

Read more

23 May 2025 15:37

News

Shilpa Medicare to conduct board meeting

Shilpa Medicare will hold a meeting of the Board of Directors of the Company on 26 May 202...

Read more

19 May 2025 16:26

News

Shilpa Medicare gains after arm receives EIR from USFDA for unit-1 facility

In an exchange filing, the company stated that the USFDA has classified the inspection out...

Read more

15 May 2025 09:56

SWOT Analysis Of Medicamen Organics Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Shilpa Medicare Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Medicamen Organics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Shilpa Medicare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Medicamen Organics Ltd and Shilpa Medicare Ltd

Which company has a larger market capitalization, Medicamen Organics Ltd or Shilpa Medicare Ltd?

Market cap of Medicamen Organics Ltd is 53 Cr while Market cap of Shilpa Medicare Ltd is 9,643 Cr

What are the key factors driving the stock performance of Medicamen Organics Ltd and Shilpa Medicare Ltd?

The stock performance of Medicamen Organics Ltd and Shilpa Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Medicamen Organics Ltd and Shilpa Medicare Ltd?

As of June 13, 2025, the Medicamen Organics Ltd stock price is INR ₹46.05. On the other hand, Shilpa Medicare Ltd stock price is INR ₹986.15.

How do dividend payouts of Medicamen Organics Ltd and Shilpa Medicare Ltd compare?

To compare the dividend payouts of Medicamen Organics Ltd and Shilpa Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions